Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
How did life begin on Earth? New experiments support 'RNA world' hypothesis - 2Unsold Rams May Be Less expensive Than You Suspect
- 3The wolf supermoon will kick off 2026 with a celestial bang. Here's when and how to see it.
- 4'Inflaming tensions': Bedouin mayor slams Ben-Gvir's unauthorized visit after meeting cancellation
- 5US FDA declines to approve Corcept's drug for rare hormonal disorder
- A definitive Cruiser Standoff: Decision in favor of Your #1 Ride
- Top 5 Top of the line Books of the Year
- Several Israelis attempt to cross into Gaza, escorted back to Israel by IDF
- CDC advisory panel delays vote on hepatitis B vaccines after unruly meeting
- France to build new nuclear aircraft carrier, Macron says
- Exploring Programming Greatness: A Survey of \Easy to use Connection points\
- Top notch Remote Earphones for Audiophiles
- Monetary Freedom Guide: Plan Your Future
- Step by step instructions to Lessen Your Gamble of Creating Cellular breakdown in the lungs
